P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES

Bibliographic Details
Main Authors:	I. Yusuf, D. Guimond, Z. Naiman, T. Schiff, B. Clemons, B. Paulson, K. Hou, K. Taylor Meadows, M. Rose, L. Carter
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847852.69497.6d

Internet